
Don't Think Too Hard About Gum
Perhaps that's why people around the world have had the impulse to gnaw on tacky materials—roots, resins, twigs, blubber, tar made by burning birch bark—for at least 8,000 years. Today, gum is again being marketed as a panacea for wellness. You can buy gum designed to deliver energy, nutrition, stress relief, or joint health; scientists are even developing gums that can protect against influenza, herpes, and COVID. Ironically, this new era of chewing gum is manufactured with a distinctly modern ingredient, one not usually associated with wellness: plastic.
By the time Wrigley began his business venture, Americans had grown accustomed to chewing gum sold as candy-coated balls or packaged sticks. The base of these chewing gums was made from natural substances such as spruce resin and chicle, a natural latex that Aztecs and Mayans chewed for hundreds if not thousands of years. Unfortunately for 20th-century Americans, the chicozapote trees that exude chicle take a long time to grow, and if they are overtapped, they die. Plus, cultivated trees don't produce nearly as much chicle as wild trees, says Jennifer Mathews, an anthropology professor at Trinity University and the author of Chicle. In the 1950s, chicle harvesters began struggling to meet demand. So gum companies turned to the newest innovations in materials science: synthetic rubbers and plastics.
Today, most companies' gum base is a proprietary blend of synthetic and natural ingredients: If a packet lists 'gum base' as an ingredient, that gum most likely contains synthetic polymers. The FDA allows gum base to contain any of dozens of approved food-grade materials—substances deemed either safe for human consumption or safe to be in contact with food. Many, though, are not substances that people would otherwise think to put in their mouth. They include polyethylene (the most common type of plastic, used in plastic bags and milk jugs), polyvinyl acetate (a plastic also found in glue), and styrene-butadiene rubber (commonly used in car tires). The typical gum base contains two to four types of synthetic plastics or rubbers, Gwendolyn Graff, a confectionery consultant, told me.
Everything we love about gum today is thanks to synthetic polymers, Graff said. Polyvinyl acetate, for example, strengthens the bubble film. 'If you blow a bubble, and it starts to get holes in it and deflate, that's usually an indicator that it doesn't have polyvinyl acetate,' Graff said. Styrene-butadiene rubber creates a bouncy chewiness that makes gum more likely to stick to itself rather than to surfaces like your teeth. Polyethylene can be used to soften gum so it doesn't tire out your jaw. Gums with only natural polymers 'can feel like they're going to fall apart in your mouth,' Graff said.
Plastic gum, though, also falls apart, in a way: Gum chewing has been linked to microplastic ingestion. In a study published in December, U.K. researchers had a volunteer chew on a piece of gum for an hour, spitting into test tubes as they went. After an hour of gum chewing, the saliva collected contained more than 250,000 pieces of micro and nano plastics—comparable to the level of microplastics found in a liter of bottled water. In a study presented at a recent meeting of the American Chemical Society (which has not yet been peer-reviewed), a graduate student's saliva contained elevated microplastic levels after she chewed several commercially available gums, including natural ones. The research on gum chewing and microplastics is still limited—these two papers effectively represent analysis of just two people's post-chew saliva—but gum chewing has also been correlated with higher urine levels of phthalates, plastic-softening chemicals that are known endocrine disruptors.
Scientists are still learning about the health impacts of microplastic ingestion, too. Microplastics find their way into all kinds of foods from packaging or contamination during manufacturing, or because the plants and animals we eat absorb and ingest microplastics themselves. As a result, microplastics have been found in human livers, kidneys, brains, lungs, intestines, placentas, and breast milk, but exactly how our bodies absorb, disperse, and excrete ingested plastic is not very well studied, says Marcus Garcia, who researches the health effects of environmental contaminants at the University of New Mexico. Some research in mice and cultured cells hint that microplastics have the potential to cause damage, and epidemiological research suggests that microplastics are associated with respiratory, digestive, and reproductive issues, as well as colon and lung cancer. But scientists are still trying to understand whether or how microplastics cause disease, which microplastics are most dangerous to human health, and how much microplastic the body can take before seeing any negative effects.
The answer could affect the future of what we choose to eat—or chew. Ingesting tiny plastic particles might seem inevitable, but over the past 10 years or so, Americans have grown understandably fearful about bits of plastic making their way into our food, fretting about microwaving food in plastic containers and drinking from plastic bottles. Gum has, for the most part, not triggered those worries, but in recent years, its popularity had been dropping for other reasons. In a bid to reverse that trend, gum companies are marketing synthetic gum as a tool for wellness. Just like Wrigley, they are betting that Americans will believe in the power of gum to soothe nerves and heal ailments, and that they won't think too hard about what modern gum really is. For anyone worried about swallowing still more plastic, after all, gum is easy enough to avoid.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
Median Technologies Files European Application for Class IIb CE Marking of Its AI-Based Software as a Medical Device for Lung Cancer Screening, eyonis® LCS
Class IIb CE marking is a prerequisite for Median's eyonis® LCS Software as a Medical Device marketing in Europe Lung cancer screening programs are already implemented in several European countries, and will be gathering pace across the continent, Eligible population in Europe is estimated at 20 million people Median previously submitted U.S. application for FDA 510(k) clearance of eyonis® LCS in May 2025 for marketing in U.S. On track for U.S. commercial launch before year-end and European launch in H1 2026, pending regulatory authorizations SOPHIA ANTIPOLIS, France, July 01, 2025--(BUSINESS WIRE)--Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company"), manufacturer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer diagnosis, and a globally leading provider of AI-based image analyses and central imaging services for oncology drug developers, announced today it has filed an application for Class IIb CE marking of eyonis® LCS (Lung Cancer Screening), its AI/ML tech-based Software as a Medical Device (SaMD) for computer aided detection and diagnosis (CADe/CADx) of lung cancer in screening programs. Concurrently to CE marking, Median has also applied for ISO 13485 certification for the Quality Management System supporting the manufacturing of eyonis ® LCS. Median Technologies applied for 510(k) clearance of eyonis® LCS with the U.S. Food and Drug Administration (FDA) on May 2025. Both regulatory filings confirm that timetables for eyonis® LCS are on track, towards commercial launch as soon as year-end 2025 in the U.S., pending FDA 510(k) clearance expected end Q3 2025, and in H1 2026 in Europe, pending Class IIb CE marking expected in Q1 2026. "Filing for CE marking of eyonis® LCS is yet another important step forward for Median, leveraging the Median eyonis® strong technology, clinical development and regulatory capabilities," said Fredrik Brag, CEO and Founder of Median Technologies. "Our regulatory submissions are built on a significant volume of positive clinical data demonstrating eyonis® LCS' safety and efficacy in REALITY and RELIVE successful pivotal studies. We are looking forward to continuing and finalizing our constructive discussions with market stakeholders, in both the U.S. and Europe, as we aim to bring eyonis® LCS to patients eligible for lung cancer screening in existing and future screening programs. Thanks to multiple institutions visits and major medical congresses attendance, our eyonis® team confirms the strong support of lung cancer key opinion leaders belonging to the pulmonology, oncology and radiology scientific bodies and societies in the U.S. and Europe. We are truly blessed with an exceptional appreciation of our highly differentiated technology, which contributes to establishing a powerful brand equity for eyonis® LCS. Additionally, our device market access strategy is already developed, ready for execution in the U.S. and tailored for specific payers to ensure maximum market penetration". Based on SOLACE project data, the overall eligible population in the EU is about 20 million people. Currently, Croatia and Poland have national Low Dose Computed Tomography (LDCT)-based lung cancer screening programs and many other European countries are conducting promising pilot programs. On June 23, 2025, LDCT-based lung cancer screening received green light in Germany for eligible people covered by statutory health insurance providers, with the policy due to go into effect in April 2026. Other European countries are moving toward lung cancer screening programs implementation, including France. In the U.S., the market opportunity includes a population of 14.5 million people, currently eligible for a LDCT lung cancer screening exam, with an existing potential reimbursement of $650 per exam with a SaMD postprocessing for characterization of malignant vs benign nodules. The eligible U.S. patient number is expected to rise in the coming years, driven by the planned broadening of the eligibility criteria. About eyonis® LCS: eyonis® Lung Cancer Screening (LCS) is an artificial intelligence AI-based computer aided detection and diagnosis (CADe/CADx) system, or Software as a Medical Device (SaMD) that uses machine learning to help analyze imaging data generated with low dose computed tomography (LDCT) to aid radiologists in diagnosis of lung cancer at the earliest stages, when it can still be cured in many patients. eyonis® LCS has been the subject of two pivotal studies required for marketing approvals in the U.S. and Europe: REALITY ( ID: NCT06576232) and RELIVE ( ID: NCT06751576), both of which have been successfully completed. Based on these pivotal data, Median Technologies submitted U.S. application for 510(k) clearance of eyonis® LCS on May 13th, 2025, and European application for CE mark on June 30th, 2025. About Median Technologies: Pioneering innovative software as a medical device and imaging services, Median Technologies harnesses cutting-edge AI to enhance the accuracy of early cancer diagnoses and treatments. Median's offerings include iCRO, which provides medical image analysis and management in oncology trials, and eyonis®, an AI/ML tech-based suite of software as a medical device (SaMD). Median empowers biopharmaceutical entities and clinicians to advance patient care and expedite the development of novel therapies. The French-based company, with a presence in the U.S. and China, trades on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is also eligible for the French SME equity savings plan scheme (PEA-PME). For more information, visit Forward-Looking Statements This press release contains forward-looking statements. These statements are not historical facts. They include projections and estimates, as well as the assumptions on which these are based, statements concerning projects, objectives, intentions, and expectations with respect to future financial results, events, operations, services, product development and potential, or future performance. These forward-looking statements can often be identified by the words "expects," "anticipates," "believes," "intends," "estimates" or "plans" and any other similar expressions. Although Median's management believes that these forward-looking statements are reasonable, investors are cautioned that forward-looking statements are subject to numerous risks and uncertainties, many of which are difficult to predict and generally beyond the control of Median Technologies, that could cause actual results and events to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. All forward-looking statements in this press release are based on information available to Median Technologies as of the date of the press release. Median Technologies does not undertake to update any forward-looking information or statements, subject to applicable regulations, in particular Articles 223-1 et seq. of the General Regulation of the French Autorité des Marchés Financiers. View source version on Contacts MEDIAN TECHNOLOGIES Emmanuelle LeyguesVP, Corporate Marketing & Financial Communications+33 6 10 93 58 Investors - SEITOSEI ACTIFIN Ghislaine Gasparetto+33 6 21 10 49 U.S. media & investors - COHESION BUREAU Chris Maggos+41 79 367 Press – ULYSSE COMMUNICATION Bruno Arabian+33 6 87 88 47 26barabian@ Nicolas Entz+33 6 33 67 31 54nentz@ Sign in to access your portfolio


New York Post
an hour ago
- New York Post
Here's what your morning routine really says about you
One in three Americans can have their mornings thrown off by missing simple steps in their routines. In a new poll of 2,000 U.S. adults, it was revealed that mornings can be easily thrown off for people if they forget to make fresh coffee or tea (38%), don't brush their teeth (34%), skip drinking water (28%), don't shower after getting out of bed (25%) or don't exercise (22%). Half can tell how their day is going to go based on how alert or tired they feel after waking up, and 49% said their morning plays a 'major' role in dictating how the rest of their day goes — especially for millennials, 57% of whom said their mornings influence the quality of their day. 4 In a new poll of 2,000 U.S. adults, it was revealed that mornings can be easily thrown off for people if they forget to make fresh coffee or tea. Graphicroyalty – In fact, 37% of respondents reported they can tell if their day is going to be good or bad just within 10 minutes of waking up. Commissioned by Naturepedic and conducted by Talker Research, the study found it takes the average person 25 minutes to feel fully awake after sleeping. Generationally, baby boomers take the least amount of time to wake up (just 19 minutes), and millennials take the longest — a full 10 minutes more than their boomer peers. Universally, morning routines take about a half hour, regardless of age or gender. 4 In fact, 37% of respondents reported they can tell if their day is going to be good or bad just within 10 minutes of waking up. Yakobchuk Olena – For respondents, typical morning routines usually consist of brushing their teeth (65%), drinking water (60%), making fresh coffee and tea (51%), clearing their eyes (48%), scrolling through missed notifications (40%) and stretching (38%). Two-thirds (62%) believe they could likely identify if a bad day was caused by having a bad start to their morning. Gen Zers are especially in-tune with this identification, as 73% believe they can tell when they're about to have a bad day. And to improve their morning, all that would be needed is an early breakfast (49%), getting fresh air (46%) or drinking just as much water as coffee or tea (42%). When looking at the data from a gender comparison, men were most likely to eat an early breakfast (53%) in order to improve their day. Women, meanwhile, were inclined to improve their day with fresh air in the morning (46%). The study found having a good day is also cyclical: 68% credit having a good day to having a good night of sleep. And 70% said having a good night of sleep leads to a good day. 4 When looking at the data from a gender comparison, men were most likely to eat an early breakfast (53%) in order to improve their day. Rido – 'It's clear that 'waking up on the right side of the bed' is more than just a turn of phrase,' commented Arin Schultz, chief growth officer at Naturepedic. 'How we spend those first few minutes of the morning is critical to make sure the rest of our day follows the right path.' According to the survey, the average person gets six hours of sleep per night, but the 'perfect' night of sleep would allow them to have one extra hour. Nearly three in four (72%) believe their day would be better if they got the 'perfect' amount of sleep. Every morning, the NY POSTcast offers a deep dive into the headlines with the Post's signature mix of politics, business, pop culture, true crime and everything in between. Subscribe here! Gen Zers are the biggest believers of this idea, as four in five of them think having the 'perfect' amount of sleep can lead to a better day. The contributors believe what can help them get the 'perfect' amount of sleep includes watching TV in bed (44%), reading (28%), drinking a glass of water (27%), putting fresh sheets on the bed (19%) and scrolling through social media (17%). For 87%, sleep isn't always completely restful. They reported feeling occasional stiffness or pain after waking up. Forty-three percent said back pain was their biggest morning irritant, followed by joint pain (37%) and neck pain (30%). Back pain was highest amongst aging Gen Xers (50%), while stiffness was the biggest issue baby boomers face after waking up (53%). 4 According to the survey, the average person gets six hours of sleep per night, but the 'perfect' night of sleep would allow them to have one extra hour. JenkoAtaman – Forty-six percent of them believe feeling stiffness or pain can have a negative impact on their day. 'Getting fresh air or drinking a glass of water in the morning can definitely help good mornings turn to good days, but sleep also plays a vital role,' continued Arin. 'Getting good quality sleep and following your natural circadian rhythm helps ensure your body is physically ready for the next day.' TOP SEVEN THINGS TO DO IN THE MORNING TO BOOST YOUR DAY Eat breakfast early in the day – 49% Get fresh air – 46% Drink just as much water as coffee/tea – 42% Stretch – 35% Take a lukewarm/cool shower – 27% Exercise before going to work – 24% Spend less than 10 minutes on your phone – 21% Survey methodology: Talker Research surveyed 2,000 general population Americans; the survey was commissioned by Naturepedic and administered and conducted online by Talker Research between May 16 and May 22, 2025.


Newsweek
an hour ago
- Newsweek
Map Shows How Many People Will Lose Healthcare in Each State Under Tax Bill
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. A number of states could see the population of Americans without health insurance increase by 5 percent if President Donald Trump's tax and spending bill is passed, according to data collected by KFF. Louisiana, Washington and Oregon are expected to see the biggest rises in the number of constituents without health insurance if the "Big Beautiful Bill" is implemented. Newsweek has contacted the Department of Health and Human Services and the Center for Medicaid and Medicare Services via email for comment. Why It Matters There has been widespread concern about the impact Trump's "Big Beautiful Bill" will have on many vulnerable Americans and their access to health care—particularly in relation to Medicaid and plans to change eligibility for the program. For example, the bill will mandate that Medicaid recipients must carry out some kind of work for at least 80 hours a month, which has prompted many healthcare experts and lawmakers to warn that it will only push them off the program. What To Know The GOP tax bill currently includes measures that would result in significant changes to the Medicaid program and the Affordable Care Act (ACA) marketplaces—changes that the Congressional Budget Office (CBO) believes will lead to more than 10 million people losing health care coverage. With the expected expiration of the ACA's enhanced premium tax credits as well, as the Trump administration does not appear set to extend them, the CBO has predicted 16 million more people will be uninsured by 2034. Of the forecasted 10 million people who will lose their health insurance, most will likely be in California, Florida, New York, and Texas, according to KFF's data. California is set to see its uninsured population rise by 1.7 million people, while Florida will see another 990,000 people uninsured. However, while these states' constituents will make up a significant proportion of the CBO's 10 million uninsured prediction if the GOP tax bill is passed, Louisiana, Washington and Oregon will experience the steepest increase based on their current number of uninsured Americans. This is because larger states, particularly those that have expanded Medicaid or have a lot of ACA Marketplace enrollees, "stand to lose more from the double whammy of Medicaid cuts and the ACA enhanced subsidies being allowed to expire," Paul Shafer, a professor in health law, policy and management at Boston University, told Newsweek. States seeing the smallest change to their uninsured population will be Alabama, Kansas, New Hampshire, South Dakota, Wisconsin and Wyoming, each expected to see an increase of 1 percent. This is due to the fact that states without Medicaid expansion "generally have smaller Medicaid enrollment as a share of population and higher uninsured rates, so they have less to lose, but that doesn't diminish the impact that losing coverage will have on thousands or more in those states," Shafer said. Jamila Michener, a professor of government and public policy at Cornell University, New York, also told Newsweek that "since more than half of Medicaid beneficiaries are Black or Latino, high coverage losses are projected in New Mexico, Louisiana, California, Texas, Florida, and New York," as in these states, people of color are more concentrated among the Medicaid eligible population. She added that it is likely more people could lose their Medicaid in states with high unemployment rates, like California, Kentucky, and Illinois, given the work requirements that will be brought in for Medicaid eligibility. There is still a lot of uncertainty as to how different states will respond to the changes in Medicaid policy, as if the federal match rate—the amount the federal government contributes to fund the program in states—is potentially reduced as well, some states may struggle to sustain the program. What People Are Saying Paul Shafer, a professor in health law, policy and management at Boston University, told Newsweek: "We know that work requirements and more frequent eligibility redeterminations will cause a lot of eligible people to drop out of Medicaid. But we don't know how states will choose to adapt their eligibility and benefits to the changes, so it is all an educated guess at this point. Whatever the exact numbers end up being, millions losing coverage will have major ramifications for their health and the financial stability of safety net and rural hospitals, in particular." He added: "Until the Senate passes their version and reconciles with House, there is potential for more changes. For example, Senator Rick Scott (R-FL) has proposed an amendment to end the enhanced match for Medicaid expansion after 2030, which could make the coverage losses larger and worsen the financial impact on states." Jamila Michener, a professor of government and public policy at Cornell University, New York, told Newsweek: "States that are racially and ethnically homogenous, have small, or nonexistent, Medicaid expansion enrollment, and have relatively low unemployment rates, like Kansas, Wyoming, Nebraska, have the lowest risk of Medicaid insurance losses. Diverse, populous states, with complex labor markets will sustain the most losses. This includes some of the states that are top contributors to the U.S. GDP like California, Texas, New York, Florida, Illinois. In essence, the reconciliation bill risks systematically destabilizing the health and well-being of our most economically critical state populations. She added: "States' choices in the wake of the reconciliation bill—especially how they decide to implement work reporting requirements—will make a big difference. States have a number of paths through which they can make the burdens imposed by the reconciliation bill lighter, decreasing coverage losses. Alternatively, states can make those burdens as heavy as possible, heightening coverage losses. No matter what happens with the reconciliation bill, it will only be the beginning." What Happens Next The GOP tax bill will continue to be deliberated in the Senate this week, with the self-imposed deadline set for July 4, meaning that after Friday, it will become clearer how the new budget bill will impact Americans across the country.